Abstract:The identification of drug-target interactions (DTIs) is a critical step in drug development. Experimental methods that are based on clinical trials to discover DTIs are time-consuming, expensive, and challenging. Therefore, as complementary to it, developing new computational methods for predicting novel DTI is of great significance with regards to saving cost and shortening the development period. In this paper, we present a novel computational model for predicting DTIs, which uses the sequence information of proteins and a rotation forest classifier. Specifically, all of the target protein sequences are first converted to a position-specific scoring matrix (PSSM) to retain evolutionary information. We then use local phase quantization (LPQ) descriptors to extract evolutionary information in the PSSM. On the other hand, substructure fingerprint information is utilized to extract the features of the drug. We finally combine the features of drugs and protein together to represent features of each drug-target pair and use a rotation forest classifier to calculate the scores of interaction possibility, for a global DTI prediction. The experimental results indicate that the proposed model is effective, achieving average accuracies of 89.15%, 86.01%, 82.20%, and 71.67% on four datasets (i.e., enzyme, ion channel, G protein-coupled receptors (GPCR), and nuclear receptor), respectively. In addition, we compared the prediction performance of the rotation forest classifier with another popular classifier, support vector machine, on the same dataset. Several types of methods previously proposed are also implemented on the same datasets for performance comparison. The comparison results demonstrate the superiority of the proposed method to the others. We anticipate that the proposed method can be used as an effective tool for predicting drug-target interactions on a large scale, given the information of protein sequences and drug fingerprints.

Identification of Drug-Target Interactions Via Multiple Information Integration.

An Ensemble Learning-Based Method for Inferring Drug-Target Interactions Combining Protein Sequences and Drug Fingerprints

A Computational Approach For Predicting Drug-Target Interactions From Protein Sequence And Drug Substructure Fingerprint Information

Predicting Drug-Target Interactions Between New Drugs and New Targets via Pairwise K-nearest Neighbor and Automatic Similarity Selection.

The Computational Models of Drug-target Interaction Prediction

Drug-Target Interaction Prediction Based On Drug Fingerprint Information And Protein Sequence

Predicting Drug-Target Interactions Via Within-Score and Between-Score

Improved Prediction Of Drug-Target Interactions Based On Ensemble Learning With Fuzzy Local Ternary Pattern

Computational Prediction of DrugTarget Interactions Using Chemical, Biological, and Network Features

Predicting Drug-Target Interaction for New Drugs Using Enhanced Similarity Measures and Super-Target Clustering.

Incorporating Chemical Sub-Structures and Protein Evolutionary Information for Inferring Drug-Target Interactions

Revealing Drug-Target Interactions with Computational Models and Algorithms

In silico prediction of drug-target interaction networks based on drug chemical structure and protein sequences

Computational Prediction of DrugTarget Interactions Using Chemical, Biological, and Network Features

A Systematic Prediction of Drug-Target Interactions Using Molecular Fingerprints and Protein Sequences

Identification of potential drug-targets by combining evolutionary information extracted from frequency profiles and molecular topological structures

A Unified Solution for Different Scenarios of Predicting Drug-Target Interactions Via Triple Matrix Factorization

Integrated Multi-Similarity Fusion and Heterogeneous Graph Inference for Drug-Target Interaction Prediction

Integrating multi-scale neighbouring topologies and cross-modal similarities for drug–protein interaction prediction

DRUG-TARGET INTERACTION PREDICTION BY INTEGRATING CHEMICAL, GENOMIC, FUNCTIONAL AND PHARMACOLOGICAL DATA

Dimensionality reduction based multi-kernel framework for drug-target interaction prediction